Key Metrics
CiteScore 

4.9
H-Index 

58
SJR 

Q3Medicine (miscellaneous)

SNIP 

0.99
Recommended pre-submission checks
Powered by 

Contrast Media and Molecular Imaging Journal Specifications
Indexed in the following public directories
Scopus
SJR
| Overview | |
| Publisher | Hindawi |
Planning to publish in Contrast Media and Molecular Imaging ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Contrast Media and Molecular Imaging
RETRACTION: Clinical Value Study on Contrast-Enhanced Ultrasound Combined with Enhanced CT in Early Diagnosis of Primary Hepatic Carcinoma.
- 1 Jan 2026
- Contrast media & molecular imaging
Correction to “Prostate Osteoblast‐Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients”
- 30 Dec 2025
- Contrast Media & Molecular Imaging
RETRACTION: The Clinical Noteworthiness of Plasma NT-ProBNP Standard in Sufferers with Cardiogenic Cerebral Embolism and Its Diagnostic Value for Such Sufferers
- 23 Sep 2025
- Contrast Media & Molecular Imaging
RETRACTION: COVID-19 Semantic Pneumonia Segmentation and Classification Using Artificial Intelligence
- 22 Sep 2025
- Contrast Media & Molecular Imaging
RETRACTION: Image Features of Resting-State Functional Magnetic Resonance Imaging in Evaluating Poor Emotion and Sleep Quality in Patients with Chronic Pain under Artificial Intelligence Algorithm
- 1 Jan 2025
- Contrast Media & Molecular Imaging
RETRACTION: The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer
- 1 Jan 2025
- Contrast Media & Molecular Imaging
RETRACTION: Clinical Value Study on Contrast-Enhanced Ultrasound Combined with Enhanced CT in Early Diagnosis of Primary Hepatic Carcinoma.
- 1 Jan 2026
- Contrast media & molecular imaging
Correction to “Prostate Osteoblast‐Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients”
- 30 Dec 2025
- Contrast Media & Molecular Imaging
RETRACTION: The Clinical Noteworthiness of Plasma NT-ProBNP Standard in Sufferers with Cardiogenic Cerebral Embolism and Its Diagnostic Value for Such Sufferers
- 23 Sep 2025
- Contrast Media & Molecular Imaging
RETRACTION: COVID-19 Semantic Pneumonia Segmentation and Classification Using Artificial Intelligence
- 22 Sep 2025
- Contrast Media & Molecular Imaging
RETRACTION: Image Features of Resting-State Functional Magnetic Resonance Imaging in Evaluating Poor Emotion and Sleep Quality in Patients with Chronic Pain under Artificial Intelligence Algorithm
- 1 Jan 2025
- Contrast Media & Molecular Imaging
RETRACTION: The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer
- 1 Jan 2025
- Contrast Media & Molecular Imaging